Evidence map›Paper›PMID 42866300›Full record

ArticleJournal of thoracic disease2026

Glycyrrhizic acid attenuates sepsis-induced acute lung injury by regulating macrophage M2 polarization via PRKCD.

Yikun Chen, Yucheng Liu, Jiayi Shen, Kerong Wang, Jun Jiang, Huazhong Cai, Jiangning Yin

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yikun ChenDepartment of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Yucheng LiuDepartment of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Jiayi ShenDepartment of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Kerong WangEmergency Department, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Jun JiangSchool of Pharmacy, Jiangsu University, Zhenjiang, China.
Huazhong CaiEmergency Department, The Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Jiangning YinEmergency Department, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although glycyrrhizic acid (GA) has anti-inflammatory properties and protein kinase C delta (PRKCD) is involved in sepsis, whether GA alleviates sepsis-induced acute lung injury (SI-ALI) by regulating macrophage polarization via PRKCD remains unclear. This study aimed to investigate the protective effects of GA in SI-ALI and explore the underlying molecular mechanisms, with a focus on macrophage polarization mediated by PRKCD. Methods: A cecal ligation and puncture (CLP) model was used to induce sepsis in mice. GA was administered intraperitoneally at different doses for Results: GA significantly alleviated CLP-induced lung tissue injury and pulmonary edema (W/D ratio: 4.5±0.8 Conclusions: GA exerts anti-inflammatory and lung-protective effects in SI-ALI, and our findings suggest that these effects are associated with PRKCD inhibition and restoration of macrophage polarization balance. These results identify PRKCD as a candidate target and support further investigation of GA as a potential therapeutic strategy for SI-ALI.

Indexed as

Glycyrrhizic acid (GA)macrophage polarizationprotein kinase C delta (PRKCD)sepsis-induced acute lung injury (SI-ALI)

Identifiers

PMID42866300
PMCPMC13656050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.